OpportunityTitle: Trans-Agency Research Consortium for Trauma-Induced Coagulopathy (TACTIC) (UM1)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Description: The purpose of the Trans-Agency Research Consortium for Trauma-Induced Coagulopathy (TACTIC) is to support a single multi-component basic collaborative Research Program to conduct hypothesis-driven studies of trauma induced coagulopathy (TIC). Through this initiative, the National Heart, Lung and Blood Institute (NHLBI) and the Department of Defense (DoD) are in partnership to form a consortium with the UM1 Research Program to address TIC research. The TACTIC program will link clinical investigators involved with ongoing DoD funded trauma-related clinical trials with the UM1 Research Program scientists who will have the unique opportunity to utilize patient samples in their basic research in TIC.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;